PVLA

Palvella Therapeutics, Inc. Common Stock

13 hedge funds and large institutions have $33.8M invested in Palvella Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 7 closing their positions.

Holders
13
Holders Change
Holders Change %
0%
% of All Funds
0.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
7
Increased
2
Reduced
1
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$13.3M 7,259,620
TCM
2
Tekla Capital Management
Massachusetts
$7.04M 3,848,191
LOAMU
3
Lombard Odier Asset Management (USA)
New York
$5.01M 2,734,799 +143,890 +6%
OFM
4
Omega Fund Management
Massachusetts
$4.55M 2,483,949 +2,483,949 New
EMFAT
5
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.74M 948,628 +43,000 +5%
SFM
6
Sphera Funds Management
Israel
$1.65M 900,000 -300,000 -25%
SM
7
Sabby Management
Florida
$276K 150,708 +150,708 New
EA
8
Emerald Advisers
Pennsylvania
$96K 52,263
TC
9
TFS Capital
Pennsylvania
$82K 44,536 +44,536 New
VKH
10
Virtu KCG Holdings
New York
$46K 24,854 +24,854 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$23K 12,868 +12,868 New
Bank of America
12
Bank of America
North Carolina
$18K 10,000 +10,000 New
OC
13
Oppenheimer & Co
New York
$18K 10,000 +10,000 New
GOCM
14
Green Owl Capital Management
New York
-450,000 Closed
PRCM
15
Pine River Capital Management
Minnesota
-350,000 Closed
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
-129,390 Closed
DCM
17
DAFNA Capital Management
California
-125,000 Closed
TDC
18
Thompson Davis & Co
Virginia
-22,500 Closed
UBS Group
19
UBS Group
Switzerland
-6,080 Closed
TRCT
20
Tower Research Capital (TRC)
New York
-500 Closed